Toll-like receptors as therapeutic targets in gastrointestinal diseases

Importance of the field: Toll-like receptors (TLRs) are innate immunity receptors that recognize several different antigens, initiating immunological/inflammatory responses. Recent evidence associates numerous pathophysiological processes and diseases with dysregulated activation of these receptors, conferring a potential therapeutic value to their modulation. Areas covered in this review: The aim of this systematic review that covers literature from the past 10 years is to address the role of TLRs in the pathophysiology of gastrointestinal (GI) diseases as well as the therapeutic potential of modulating TLRs' signaling pathways in GI pathology. What the reader will gain: This review shows that TLRs play an important role in the pathophysiology of several GI diseases and that modulating TLRs signaling pathways may have an enormous therapeutic potential. Different methods for modulation of TLRs' activity in GI tract, with direct agonists/antagonists but also with non-specific substances, like antibiotics or probiotics, are presented. Take home message: Even though TLRs modulators have been used for therapy in some GI diseases, further research, particularly in humans, is needed in order to establish the precise role of the different TLRs in the diverse GI diseases and to motivate clinical trials that consider TLRs as therapeutic targets in GI pathology.

[1]  P. Angus,et al.  Effects of antibiotics on expression and function of Toll-like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosis. , 2010, Journal of hepatology.

[2]  S. Snapper,et al.  Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice. , 2009, Gastroenterology.

[3]  Olivia T. Abar,et al.  Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. , 2009, Journal of hepatology.

[4]  K. Tominaga,et al.  Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[5]  Y. Li,et al.  Protective effect of bicyclol on liver injury induced by hepatic warm ischemia/reperfusion in rats , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  B. Evers,et al.  Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells. , 2009, Anticancer research.

[7]  B. Müller-Myhsok,et al.  Epistasis Between Toll-Like Receptor-9 Polymorphisms and Variants in NOD2 and IL23R Modulates Susceptibility to Crohn's Disease , 2009, The American Journal of Gastroenterology.

[8]  G. Gerken,et al.  Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. , 2009, Gastroenterology.

[9]  H. Herfarth,et al.  Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility , 2009, PloS one.

[10]  R. Moon,et al.  Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration , 2009, Clinical Cancer Research.

[11]  K. Matsuo,et al.  Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies , 2009, Gut.

[12]  Tomohiro Watanabe,et al.  Isoflavones regulate innate immunity and inhibit experimental colitis , 2009, Journal of gastroenterology and hepatology.

[13]  R. Xu,et al.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[14]  T. Tsujimoto,et al.  Therapeutic approach to regulate innate immune response by Toll‐like receptor 4 antagonist E5564 in rats with D‐galactosamine‐induced acute severe liver injury , 2009, Journal of gastroenterology and hepatology.

[15]  C. Prinz,et al.  Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. , 2009, Gastroenterology.

[16]  L. N. Valenti,et al.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease? , 2009, Seminars in Immunopathology.

[17]  Bin Zhou,et al.  Potential role of the TLR4/IRAK-4 signaling pathway in the pathophysiology of acute pancreatitis in mice , 2009, Inflammation Research.

[18]  A. Leite-Moreira,et al.  M1722 Attenuation of Toll-Like Receptor 2 Activation in Alcoholic Chronic Liver Disease: A Mechanism for Acquired Immunodeficiency? , 2009 .

[19]  H. Cao,et al.  Hepatitis B virus DNA-induced carcinogenesis of human normal liver cells by virtue of nonmethylated CpG DNA. , 2009, Oncology reports.

[20]  G. Gerken,et al.  Hepatitis B virus suppresses toll‐like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells , 2009, Hepatology.

[21]  A. Masamune,et al.  Microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene is associated with susceptibility to acute pancreatitis in Japan. , 2009, Human immunology.

[22]  Olivia T. Abar,et al.  Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses , 2009, Hepatology.

[23]  T. Miyazaki,et al.  Toll-like receptor 3 signaling induces chronic pancreatitis through the Fas/Fas ligand-mediated cytotoxicity. , 2009, The Tohoku journal of experimental medicine.

[24]  S. Targan,et al.  High‐frequency Haplotypes in the X Chromosome Locus TLR8 Are Associated With Both CD and UC in Females , 2009, Inflammatory bowel diseases.

[25]  G. Rogler,et al.  Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. , 2009, The Journal of nutrition.

[26]  Hong-Wei Sun,et al.  Effects of Trefoil Peptide 3 on Expression of TNF-α, TLR4, and NF-κB in Trinitrobenzene Sulphonic Acid Induced Colitis Mice , 2009, Inflammation.

[27]  B. Beutler.  TLRs and innate immunity. , 2009, Blood.

[28]  S. Im,et al.  CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells. , 2009, Cancer letters.

[29]  E. Kurt-Jones,et al.  Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice , 2009, Gut.

[30]  R. Ray,et al.  Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog , 2009, Proceedings of the National Academy of Sciences.

[31]  F. Sutterwala,et al.  Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. , 2009, The Journal of clinical investigation.

[32]  K. Matsuo,et al.  Toll‐Like Receptor 4 +3725 G/C Polymorphism, Helicobacter pylori Seropositivity, and the Risk of Gastric Atrophy and Gastric Cancer in Japanese , 2009, Helicobacter.

[33]  C. Huh,et al.  Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-κB activation in experimental colitis , 2009, International Journal of Colorectal Disease.

[34]  R. Schwabe,et al.  Toll-like receptors, wound healing, and carcinogenesis , 2009, Journal of Molecular Medicine.

[35]  M. Oriowo,et al.  Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis , 2009, Molecular and Cellular Biochemistry.

[36]  D. Gorden,et al.  Silencing of TLR4 Decreases Liver Tumor Burden in a Murine Model of Colorectal Metastasis and Hepatic Steatosis , 2009, Annals of Surgical Oncology.

[37]  L. Andresen,et al.  Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease , 2009, Scandinavian journal of gastroenterology.

[38]  J. Ozolek,et al.  Reciprocal Expression and Signaling of TLR4 and TLR9 in the Pathogenesis and Treatment of Necrotizing Enterocolitis1 , 2009, The Journal of Immunology.

[39]  Xuetao Cao,et al.  Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation. , 2008, International immunopharmacology.

[40]  T. Robak,et al.  Toll-like receptors and their role in carcinogenesis and anti-tumor treatment , 2008, Cellular & Molecular Biology Letters.

[41]  B. Vincenzi,et al.  Toll‐like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes , 2008, Clinical and experimental immunology.

[42]  J. Ricci,et al.  Comparative Proteomics Study Reveals That Bacterial CpG Motifs Induce Tumor Cell Autophagy in Vitro and in Vivo*S , 2008, Molecular & Cellular Proteomics.

[43]  H. Yoshiji,et al.  Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet. , 2008, World journal of gastroenterology.

[44]  C. Hellerbrand,et al.  Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. , 2008, Biochemical and biophysical research communications.

[45]  M. Fischer,et al.  Toll‐like Receptors in Autoimmunity , 2008, Annals of the New York Academy of Sciences.

[46]  C. Maldonado-Bernal,et al.  TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. , 2008, Clinical immunology.

[47]  C. Hellerbrand,et al.  A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. , 2008, Biochemical and biophysical research communications.

[48]  G. Dijkstra,et al.  Role of alkaline phosphatase in colitis in man and rats , 2008, Gut.

[49]  A. Dolganiuc,et al.  The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 , 2008, Hepatology.

[50]  Zhan-qing Zhang,et al.  Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. , 2008, Clinical immunology.

[51]  Gary Hardiman,et al.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. , 2008, Cancer cell.

[52]  Bin Zhou,et al.  Extracellular heat-shock protein 70 aggravates cerulein-induced pancreatitis through toll-like receptor-4 in mice. , 2008, Chinese medical journal.

[53]  N. Barnich,et al.  Crohn's disease‐associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin , 2008, Inflammatory bowel diseases.

[54]  H. Wong,et al.  Activation of hepatocytes by extracellular heat shock protein 72. , 2008, American journal of physiology. Cell physiology.

[55]  C. Pothoulakis,et al.  Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer. , 2008, Gastroenterology.

[56]  M. Koziel,et al.  Immune responses during acute and chronic infection with hepatitis C virus. , 2008, Clinical immunology.

[57]  A. Masamune,et al.  Pancreatic stellate cells express Toll-like receptors , 2008, Journal of Gastroenterology.

[58]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[59]  G. Gerken,et al.  Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. , 2008, Journal of hepatology.

[60]  C. Martínez,et al.  VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4 , 2008, Peptides.

[61]  R. Jalan,et al.  Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. , 2008, Journal of hepatology.

[62]  N. Shinomiya,et al.  Helicobacter pylori Augments Growth of Gastric Cancers via the Lipopolysaccharide-Toll-like Receptor 4 Pathway whereas Its Lipopolysaccharide Attenuates Antitumor Activities of Human Mononuclear Cells , 2008, Clinical Cancer Research.

[63]  J. Lundahl,et al.  Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis , 2008, Journal of Gastroenterology.

[64]  M. Bedoni,et al.  Cross-talk among Toll-like receptors and their ligands. , 2008, International immunology.

[65]  L. Griffiths,et al.  Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population , 2008, Inflammatory bowel diseases.

[66]  M. Murr,et al.  Deletion of toll-like receptor-4 downregulates protein kinase C-zeta and attenuates liver injury in experimental pancreatitis. , 2008, Surgery.

[67]  Xuetao Cao,et al.  Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation. , 2008, Molecular immunology.

[68]  G. Cheng,et al.  Evidence for the Pivotal Role of Endogenous Toll-Like Receptor 4 Ligands in Liver Ischemia and Reperfusion Injury , 2008, Transplantation.

[69]  A. Osterman,et al.  An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models , 2008, Science.

[70]  T. Tahara,et al.  Toll-like Receptor 2 (TLR) −196 to 174del Polymorphism in Gastro-duodenal Diseases in Japanese Population , 2008, Digestive Diseases and Sciences.

[71]  M. Membrez,et al.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  Bin Zhou,et al.  Toll-like receptor 9 is expressed in rat pancreas and is involved in cerulein-induced pancreatitis. , 2008, Pancreas.

[73]  K. Tsuneyama,et al.  Biliary epithelial cells and primary biliary cirrhosis: The role of liver‐infiltrating mononuclear cells , 2008, Hepatology.

[74]  J. Prieto,et al.  Inflammation, HCC and sex: IL-6 in the centre of the triangle. , 2008, Journal of hepatology.

[75]  A. Chen,et al.  Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF‐κB and ERK signalling , 2008, British journal of pharmacology.

[76]  M. Abreu,et al.  Role of Toll-like receptors in gastrointestinal malignancies , 2008, Oncogene.

[77]  M. Shiina,et al.  Cell culture–produced hepatitis C virus impairs plasmacytoid dendritic cell function , 2007, Hepatology.

[78]  S. Akira,et al.  Deletion of TLR5 results in spontaneous colitis in mice. , 2007, The Journal of clinical investigation.

[79]  G. Gerken,et al.  Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice , 2007, Hepatology.

[80]  M. Lotze,et al.  The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity , 2007, Immunological reviews.

[81]  H. Li,et al.  The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. , 2007, Transplantation proceedings.

[82]  B. Beutler.  Neo‐ligands for innate immune receptors and the etiology of sterile inflammatory disease , 2007, Immunological reviews.

[83]  R. Xu,et al.  Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. , 2007, Gastroenterology.

[84]  G. Veres,et al.  Increased expression of Toll‐like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease , 2007, Clinical and experimental immunology.

[85]  A. Dolganiuc,et al.  Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. , 2007, Gastroenterology.

[86]  U. Ghoshal,et al.  Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. , 2007, Human immunology.

[87]  A. Shelling,et al.  Has Toll-Like Receptor 4 Been Prematurely Dismissed as an Inflammatory Bowel Disease Gene? Association Study Combined With Meta-Analysis Shows Strong Evidence for Association , 2007, The American Journal of Gastroenterology.

[88]  T. Tahara,et al.  Toll‐like receptor 2 –196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer , 2007, Cancer science.

[89]  B. Bacon,et al.  Phase 1B, randomized, double‐blind, dose‐escalation trial of CPG 10101 in patients with chronic hepatitis C virus , 2007, Hepatology.

[90]  H. Morita,et al.  Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[91]  D. A. Gomes,et al.  Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll‐like receptor 9 , 2007, Hepatology.

[92]  Tomohiro Watanabe,et al.  NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. , 2007, Gastroenterology.

[93]  D. Hackam,et al.  A Critical Role for TLR4 in the Pathogenesis of Necrotizing Enterocolitis by Modulating Intestinal Injury and Repair1 , 2007, The Journal of Immunology.

[94]  F. Gao,et al.  Absence of toll‐like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[95]  P. Pristovsek,et al.  MD‐2 as the target of curcumin in the inhibition of response to LPS , 2007, Journal of leukocyte biology.

[96]  P. Adegboyega,et al.  Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. , 2007, Journal of hepatology.

[97]  Rakesh K. Kumar,et al.  Bacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal model. , 2007, Gastroenterology.

[98]  K. Takeuchi,et al.  Increased susceptibility of small intestine to NSAID-provoked ulceration in rats with adjuvant-induced arthritis: involvement of enhanced expression of TLR4. , 2007, Life sciences.

[99]  Y. Takeyama,et al.  Role of Toll-Like Receptor 4 in the Pathophysiology of Severe Acute Pancreatitis in Mice , 2007, Surgery Today.

[100]  Chang‐you Wu,et al.  Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination. , 2007, Biochemical and biophysical research communications.

[101]  C. Rosenberger,et al.  Toll‐like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium‐induced colitis , 2007, Cellular microbiology.

[102]  A. Dolganiuc,et al.  Toll‐like receptors 1 and 6 are involved in TLR2‐mediated macrophage activation by hepatitis C virus core and NS3 proteins , 2007, Journal of leukocyte biology.

[103]  M. Takamura,et al.  Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis. , 2007, Journal of hepatology.

[104]  G. Veres,et al.  Increased Mucosal Expression of Toll-like Receptor (TLR)2 and TLR4 in Coeliac Disease , 2007, Journal of pediatric gastroenterology and nutrition.

[105]  Olivia T. Abar,et al.  A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C , 2007, Hepatology.

[106]  D. Jäger,et al.  Intratumoural injection of the toll-like receptor-2/6 agonist ‘macrophage-activating lipopeptide-2’ in patients with pancreatic carcinoma: a phase I/II trial , 2007, British Journal of Cancer.

[107]  U. Göbel,et al.  Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 , 2007, PloS one.

[108]  G. Fontanini,et al.  TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts , 2007, Proceedings of the National Academy of Sciences.

[109]  K. Tominaga,et al.  Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent , 2007, Gut.

[110]  M. Daly,et al.  The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases , 2007, Genes and Immunity.

[111]  M. Falagas,et al.  Bacterial Infection-Related Morbidity and Mortality in Cirrhosis , 2007, The American Journal of Gastroenterology.

[112]  A. Gewirtz,et al.  Activation of toll‐like receptor 3 protects against DSS‐induced acute colitis , 2007, Inflammatory bowel diseases.

[113]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[114]  C. Prinz,et al.  Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. , 2007, Gastroenterology.

[115]  Yuan Tian,et al.  N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice. , 2007, Hepatobiliary & pancreatic diseases international : HBPD INT.

[116]  S. Akira,et al.  Hepatitis C Virus Nonstructural Protein 5A Modulates the Toll-Like Receptor-MyD88-Dependent Signaling Pathway in Macrophage Cell Lines , 2007, Journal of Virology.

[117]  M. Walker,et al.  TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: Results from a genome‐wide scan , 2007, European journal of immunology.

[118]  Hui Wang,et al.  Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53. , 2007, International journal of oncology.

[119]  R. Sun,et al.  NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice , 2007, Proceedings of the National Academy of Sciences.

[120]  I. Sheen,et al.  Endotoxemia contributes to the immune paralysis in patients with cirrhosis. , 2007, Journal of hepatology.

[121]  S. Targan,et al.  Anti‐flagellin (CBir1) phenotypic and genetic Crohn's disease associations , 2007, Inflammatory bowel diseases.

[122]  K. Fukase,et al.  Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. , 2007, Molecular immunology.

[123]  H. Xiong,et al.  Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. , 2007, Cancer research.

[124]  G Gerken,et al.  Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. , 2007, Gastroenterology.

[125]  M. Caplan,et al.  Polyunsaturated Fatty Acid Supplementation Alters Proinflammatory Gene Expression and Reduces the Incidence of Necrotizing Enterocolitis in a Neonatal Rat Model , 2007, Pediatric Research.

[126]  H. Giladi,et al.  TLR3 signaling in a hepatoma cell line is skewed towards apoptosis , 2007, Journal of cellular biochemistry.

[127]  R. Sun,et al.  Recognition of Double-Stranded RNA by TLR3 Induces Severe Small Intestinal Injury in Mice1 , 2007, The Journal of Immunology.

[128]  M. Lederman,et al.  TLR Ligand-Dependent Activation of Naive CD4 T Cells by Plasmacytoid Dendritic Cells Is Impaired in Hepatitis C Virus Infection1 , 2007, The Journal of Immunology.

[129]  S. Akira,et al.  Deficiencies of Myeloid Differentiation Factor 88, Toll-Like Receptor 2 (TLR2), or TLR4 Produce Specific Defects in Macrophage Cytokine Secretion Induced by Helicobacter pylori , 2007, Infection and Immunity.

[130]  E. El-Omar,et al.  A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. , 2007, Gastroenterology.

[131]  Jinxiang Zhang,et al.  Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll‐like receptor 4/nuclear factor‐kappa B pathway , 2007, Chinese medical journal.

[132]  P. Brun,et al.  Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[133]  U. Göbel,et al.  Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli , 2007, Gut.

[134]  S. Lewin,et al.  Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.

[135]  Yu-Tseung Liu,et al.  Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells , 2006, Nature Cell Biology.

[136]  R. Thomson,,et al.  The Roles of Bacteria and TLR4 in Rat and Murine Models of Necrotizing Enterocolitis1 , 2006, The Journal of Immunology.

[137]  R. Xu,et al.  Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. , 2006, Gastroenterology.

[138]  Tomohiro Watanabe,et al.  Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. , 2006, Immunity.

[139]  E. Valletta,et al.  In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-Like Receptor 4 and Induces Activation of Monocytes , 2006, PLoS medicine.

[140]  J. Terzic,et al.  Microsatelite GT polymorphism in the toll‐like receptor 2 is associated with colorectal cancer , 2006, Clinical genetics.

[141]  Ruslan Medzhitov,et al.  Role of toll-like receptors in spontaneous commensal-dependent colitis. , 2006, Immunity.

[142]  S. Riordan,et al.  Reduced Expression of Toll-Like Receptor 2 on Peripheral Monocytes in Patients with Chronic Hepatitis B , 2006, Clinical and Vaccine Immunology.

[143]  Jongdae Lee,et al.  Homeostatic Effects of TLR9 Signaling in Experimental Colitis , 2006, Annals of the New York Academy of Sciences.

[144]  C. Martínez,et al.  Effect of VIP on TLR2 and TLR4 Expression in Lymph Node Immune Cells During TNBS‐Induced Colitis , 2006, Annals of the New York Academy of Sciences.

[145]  S. Wrighton,et al.  Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[146]  Judy H Cho,et al.  Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[147]  Christopher J. Parsons,et al.  LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[148]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[149]  F. Liew,et al.  Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[150]  Jongdae Lee,et al.  Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis. , 2006, Inflammatory bowel diseases.

[151]  D. Franchimont,et al.  Differential liver sensitization to Toll‐like receptor pathways in mice with alcoholic fatty liver , 2006, Hepatology.

[152]  R. Schwabe,et al.  Toll-like receptor signaling in the liver. , 2006, Gastroenterology.

[153]  J. Rodríguez-Sánchez,et al.  TNFα production to TLR2 ligands in active IBD patients , 2006 .

[154]  M. D’Elios,et al.  The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. , 2006, The Journal of clinical investigation.

[155]  D. Han,et al.  Attenuation of Colonic Inflammation by PPARγ in Intestinal Epithelial Cells: Effect on Toll-like Receptor Pathway , 2006, Digestive Diseases and Sciences.

[156]  Huiping Wang,et al.  Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. , 2006, European journal of pharmacology.

[157]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[158]  A. Fasano,et al.  Gliadin Stimulation of Murine Macrophage Inflammatory Gene Expression and Intestinal Permeability Are MyD88-Dependent: Role of the Innate Immune Response in Celiac Disease1 , 2006, The Journal of Immunology.

[159]  Lei Zhang,et al.  Role of nitric oxide in Toll-like receptor 2 and 4 mRNA expression in liver of acute hemorrhagic necrotizing pancreatitis rats. , 2006, World journal of gastroenterology.

[160]  A. Leonardi,et al.  Novel Toll-Like Receptor 9 Agonist Induces Epidermal Growth Factor Receptor (EGFR) Inhibition and Synergistic Antitumor Activity with EGFR Inhibitors , 2006, Clinical Cancer Research.

[161]  M. Lai,et al.  Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6 , 2006, Journal of Virology.

[162]  Paul J Hertzog,et al.  Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation , 2006, Nature Immunology.

[163]  P. Rutgeerts,et al.  Toll‐like receptor‐1, ‐2, and ‐6 polymorphisms influence disease extension in inflammatory bowel diseases , 2006, Inflammatory bowel diseases.

[164]  Jaw-Town Lin,et al.  Helicobacter pylori-Induced Invasion and Angiogenesis of Gastric Cells Is Mediated by Cyclooxygenase-2 Induction through TLR2/TLR9 and Promoter Regulation1 , 2005, The Journal of Immunology.

[165]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[166]  Ruslan Medzhitov,et al.  Control of B-cell responses by Toll-like receptors , 2005, Nature.

[167]  L. Romics,et al.  Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. , 2005, Alcoholism, clinical and experimental research.

[168]  Lei Zhang,et al.  Effect of nitric oxide on toll-like receptor 2 and 4 gene expression in rats with acute lung injury complicated by acute hemorrhage necrotizing pancreatitis. , 2005, Hepatobiliary & pancreatic diseases international : HBPD INT.

[169]  H. Davis,et al.  TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848). , 2005, Vaccine.

[170]  Xingpeng Wang,et al.  Roles of Endotoxin-related Signaling Molecules in the Progression of Acute Necrotizing Pancreatitis in Mice , 2005, Pancreas.

[171]  R. Coppel,et al.  Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis , 2005, Hepatology.

[172]  C. Pothoulakis,et al.  Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[173]  Y. Shaul,et al.  Cytokine Induction by the Hepatitis B Virus Capsid in Macrophages Is Facilitated by Membrane Heparan Sulfate and Involves TLR2 , 2005, The Journal of Immunology.

[174]  C. Hofmann,et al.  CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. , 2005, Gastroenterology.

[175]  T. Berg,et al.  Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection , 2005, Hepatology.

[176]  Masahiro Ito,et al.  Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. , 2005, Journal of autoimmunity.

[177]  G. Macfarlane,et al.  Toll‐like receptors‐2, ‐3 and ‐4 expression patterns on human colon and their regulation by mucosal‐associated bacteria , 2005, Immunology.

[178]  Jinxiang Zhang,et al.  Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. , 2005, World journal of gastroenterology.

[179]  S. Ménard,et al.  Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft. , 2005, Cancer research.

[180]  P. Greer,et al.  Absence of Fer protein tyrosine kinase exacerbates endotoxin induced intestinal epithelial barrier dysfunction in vivo , 2005, Gut.

[181]  Francesco Bertoni,et al.  Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells , 2005, Nature Immunology.

[182]  Masahiro Ito,et al.  Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis , 2005, Laboratory Investigation.

[183]  A. Aderem,et al.  Evasion of Toll-like receptor 5 by flagellated bacteria. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[184]  H. Müller-Hermelink,et al.  Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. , 2005, International journal of medical microbiology : IJMM.

[185]  Yibang Chen,et al.  Toll-like receptors on tumor cells facilitate evasion of immune surveillance. , 2005, Cancer research.

[186]  F. Chisari,et al.  Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo , 2005, Journal of Virology.

[187]  K. Isse,et al.  Th1 cytokine–induced downregulation of PPARγ in human biliary cells relates to cholangitis in primary biliary cirrhosis , 2005, Hepatology.

[188]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.

[189]  R. Coppel,et al.  Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. , 2005, Journal of autoimmunity.

[190]  S. Sriskandan,et al.  Mammalian Toll‐like receptors: to immunity and beyond , 2005, Clinical and experimental immunology.

[191]  D. Persing,et al.  A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease 1 , 2005, The Journal of Immunology.

[192]  W. Falk,et al.  In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis , 2005, Gut.

[193]  N. Kato,et al.  Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses , 2005, Hepatology.

[194]  R. Xu,et al.  Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[195]  Asima Bhattacharyya,et al.  The Secreted Peptidyl Prolyl cis,trans-Isomerase HP0175 of Helicobacter pylori Induces Apoptosis of Gastric Epithelial Cells in a TLR4- and Apoptosis Signal-Regulating Kinase 1-Dependent Manner1 , 2005, The Journal of Immunology.

[196]  G. Garcia‐Tsao.  Bacterial infections in cirrhosis: treatment and prophylaxis. , 2005, Journal of hepatology.

[197]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[198]  B. Rehermann,et al.  Immunology of hepatitis B virus and hepatitis C virus infection , 2005, Nature Reviews Immunology.

[199]  J. Goldberg,et al.  Helicobacter pylori Induces Interleukin-8 Secretion by Toll-Like Receptor 2- and Toll-Like Receptor 5-Dependent and -Independent Pathways , 2005, Infection and Immunity.

[200]  Stanley M Lemon,et al.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[201]  A. Oatridge,et al.  Fatigue in primary biliary cirrhosis , 2005, Gut.

[202]  M. Gazouli,et al.  Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. , 2005, World journal of gastroenterology.

[203]  M. Kaplan,et al.  Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. , 2005, Gastroenterology.

[204]  Ryan M. O’Connell,et al.  Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway1 , 2004, The Journal of Immunology.

[205]  F. Re,et al.  IL-10 Released by Concomitant TLR2 Stimulation Blocks the Induction of a Subset of Th1 Cytokines That Are Specifically Induced by TLR4 or TLR3 in Human Dendritic Cells1 , 2004, The Journal of Immunology.

[206]  K. Hahm,et al.  Protective Mechanism of Epigallocatechin‐3‐Gallate against Helicobacter pylori‐Induced Gastric Epithelial Cytotoxicity via the Blockage of TLR‐4 Signaling , 2004, Helicobacter.

[207]  Jaw-Town Lin,et al.  Induction of Cyclooxygenase-2 Overexpression in Human Gastric Epithelial Cells by Helicobacter pylori Involves TLR2/TLR9 and c-Src-Dependent Nuclear Factor-κB Activation , 2004, Molecular Pharmacology.

[208]  Y. Shiratori,et al.  Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. , 2004, Microbiology.

[209]  Shizuo Akira,et al.  Pleiotropic function of Toll-like receptors. , 2004, Microbes and infection.

[210]  A. Cocchiarella,et al.  Intact Gram-Negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus Bacteria Activate Innate Immunity via Toll-Like Receptor 2 but Not Toll-Like Receptor 4 , 2004, Infection and Immunity.

[211]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[212]  D. Golenbock,et al.  Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. , 2004, Gastroenterology.

[213]  C. Cooper,et al.  CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study , 2004, Journal of Clinical Immunology.

[214]  H. Mustonen,et al.  Proinflammatory effects of pancreatic elastase are mediated through TLR4 and NF-kappaB. , 2004, Biochemical and biophysical research communications.

[215]  F. Re,et al.  Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunity. , 2004, Immunobiology.

[216]  F. Mach,et al.  Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia , 2004, Critical care medicine.

[217]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[218]  N. Ishimura,et al.  Essential Role of MD-2 in TLR4-Dependent Signaling during Helicobacter pylori-Associated Gastritis , 2004, The Journal of Immunology.

[219]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[220]  J. Glas,et al.  Crohn's disease is associated with a toll-like receptor-9 polymorphism. , 2004, Gastroenterology.

[221]  G. Gerken,et al.  Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. , 2004, Gastroenterology.

[222]  James Armitage,et al.  Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group , 2004, Annals of Internal Medicine.

[223]  K. Van Steen,et al.  Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis , 2004, Gut.

[224]  R. Peek,et al.  Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. , 2004, The Journal of infectious diseases.

[225]  Hui Wang,et al.  Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. , 2004, Hepatobiliary & pancreatic diseases international : HBPD INT.

[226]  R. Ulevitch,et al.  Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors , 2004, Nature Immunology.

[227]  D. Podolsky,et al.  Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. , 2004, Gastroenterology.

[228]  L. Wen,et al.  The Effect of Innate Immunity on Autoimmune Diabetes and the Expression of Toll-Like Receptors on Pancreatic Islets1 , 2004, The Journal of Immunology.

[229]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[230]  S. Akira,et al.  Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. , 2004, Gastroenterology.

[231]  A. Gobert,et al.  Helicobacter pylori Heat Shock Protein 60 Mediates Interleukin-6 Production by Macrophages via a Toll-like Receptor (TLR)-2-, TLR-4-, and Myeloid Differentiation Factor 88-independent Mechanism* , 2004, Journal of Biological Chemistry.

[232]  J. Platt,et al.  Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 41 , 2004, The Journal of Immunology.

[233]  C. Josenhans,et al.  Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. , 2003, Microbes and infection.

[234]  K. Michelsen,et al.  TLR signaling at the intestinal epithelial interface , 2003, Journal of endotoxin research.

[235]  J. Goldberg,et al.  Toll-like Receptor (TLR) 2 and TLR5, but Not TLR4, Are Required for Helicobacter pylori-induced NF-κB Activation and Chemokine Expression by Epithelial Cells* , 2003, Journal of Biological Chemistry.

[236]  Roger Williams,et al.  Peripheral blood mononuclear cell expression of toll‐like receptors and relation to cytokine levels in cirrhosis , 2003, Hepatology.

[237]  Christian Jobin,et al.  Toll‐Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells , 2003, Hepatology.

[238]  S. Solga,et al.  Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. , 2003, Journal of hepatology.

[239]  J. Udagawa,et al.  Strategic Compartmentalization of Toll-Like Receptor 4 in the Mouse Gut1 , 2003, The Journal of Immunology.

[240]  T. Sauerbruch,et al.  Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model , 2003, Gut.

[241]  A. Moser,et al.  Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.

[242]  K. Michelsen,et al.  Human Intestinal Epithelial Cells Are Broadly Unresponsive to Toll-Like Receptor 2-Dependent Bacterial Ligands: Implications for Host-Microbial Interactions in the Gut 1 , 2003, The Journal of Immunology.

[243]  S. Akira,et al.  Recognition of pathogen-associated molecular patterns by TLR family. , 2003, Immunology letters.

[244]  J. Schölmerich,et al.  CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium‐treated mice , 2002, European journal of immunology.

[245]  Ruslan Medzhitov,et al.  Control of adaptive immune responses by Toll-like receptors. , 2002, Current opinion in immunology.

[246]  J. Platt,et al.  Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 41 , 2002, The Journal of Immunology.

[247]  Jongdae Lee,et al.  Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. , 2002, Gastroenterology.

[248]  K. Hu.  Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors. , 2002, The Journal of laboratory and clinical medicine.

[249]  吉岡 孝.  Bacterial lipopolysaccharide induces transforming growth factor β and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells , 2002 .

[250]  G. Arteel,et al.  Role of Lipopolysaccharide-Binding Protein in Early Alcohol-Induced Liver Injury in Mice1 , 2002, The Journal of Immunology.

[251]  N. Kobayashi,et al.  Bacterial Lipopolysaccharide Induces Transforming Growth Factor β and Hepatocyte Growth Factor through Tolllike Receptor 2 in Cultured Human Colon Cancer Cells , 2001, The Journal of international medical research.

[252]  Rajnish A. Gupta,et al.  Activation of Peroxisome Proliferator-activated Receptor γ Suppresses Nuclear Factor κB-mediated Apoptosis Induced by Helicobacter pylori in Gastric Epithelial Cells* , 2001, The Journal of Biological Chemistry.

[253]  P. Godowski,et al.  Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5 to Induce Epithelial Proinflammatory Gene Expression1 , 2001, The Journal of Immunology.

[254]  T. Kawai,et al.  Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. , 2001, The journal of medical investigation : JMI.

[255]  M. Abreu,et al.  Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide1 , 2001, The Journal of Immunology.

[256]  G. Arteel,et al.  Toll‐like receptor 4 is involved in the mechanism of early alcohol‐induced liver injury in mice , 2001, Hepatology.

[257]  G. Rogler,et al.  Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. , 2001, Gastroenterology.

[258]  R. Strieter.  Chemokines: Not just leukocyte chemoattractants in the promotion of cancer , 2001, Nature Immunology.

[259]  S. Goyert,et al.  Reduced Early Alcohol-Induced Liver Injury in CD14-Deficient Mice1 , 2001, The Journal of Immunology.

[260]  S. Akira,et al.  Lipopolysaccharide-Induced IL-18 Secretion from Murine Kupffer Cells Independently of Myeloid Differentiation Factor 88 That Is Critically Involved in Induction of Production of IL-12 and IL-1β1 , 2001, The Journal of Immunology.

[261]  D. Podolsky,et al.  Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease , 2000, Infection and Immunity.

[262]  C. Bode,et al.  Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. , 2000, Journal of hepatology.

[263]  S. Akira,et al.  Cutting Edge: Endotoxin Tolerance in Mouse Peritoneal Macrophages Correlates with Down-Regulation of Surface Toll-Like Receptor 4 Expression1 , 2000, The Journal of Immunology.

[264]  F. Chisari,et al.  Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines , 2000, Journal of Virology.

[265]  D. Kerjaschki,et al.  Association between intraepithelial Escherichia coli and colorectal cancer. , 1998, Gastroenterology.

[266]  S. D. Lee,et al.  Prognostic value of plasma endotoxin levels in patients with cirrhosis. , 1997, Scandinavian journal of gastroenterology.

[267]  C. Müller,et al.  Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. , 1995, Journal of hepatology.

[268]  E. Wisse,et al.  Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia. , 1995, Journal of hepatology.

[269]  S. D. Lee,et al.  Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. , 1995, Journal of hepatology.

[270]  John I. Allen,et al.  The role of tumor necrosis factor‐α in acute endotoxin‐induced hepatotoxicity in ethanol‐fed rats , 1994 .

[271]  A. Nanji,et al.  Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. , 1994, The Journal of pharmacology and experimental therapeutics.

[272]  B. Drumm,et al.  Adherence of Helicobacter pylori to primary human gastrointestinal cells , 1993, Infection and immunity.

[273]  C. Bode,et al.  Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. , 1991, Journal of hepatology.

[274]  G. Laqueur,et al.  Comparison of the carcinogenicity of methylazoxymethanol-beta-D-glucosiduronic acid in conventional and germfree Sprague-Dawley rats. , 1981, Journal of the National Cancer Institute.

[275]  J. Fine,et al.  THE ROLE OF INTESTINAL BACTERIA IN THE DEVELOPMENT OF DIETARY CIRRHOSIS IN RATS , 1957, The Journal of experimental medicine.

[276]  L. Eckmann,et al.  Amendment history : Corrigendum ( April 2005 ) Toll-like receptor 9 – induced type I IFN protects mice from experimental colitis , 2018 .

[277]  R. Brůha,et al.  Alcoholic liver disease. , 2012, World journal of hepatology.

[278]  K. Shiraki,et al.  Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. , 2008, International journal of oncology.

[279]  宮崎 昌典.  Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I , 2008 .

[280]  D. Jaffe.  Bacterial Endotoxin: A Trigger Factor for Alcoholic Pancreatitis? Evidence From a Novel, Physiologically Relevant Animal Model , 2008 .

[281]  Y. Takeyama,et al.  Decreased expression of Toll-like receptor 2 and 4 on macrophages in experimental severe acute pancreatitis. , 2007, The Kobe journal of medical sciences.

[282]  R. Schwabe,et al.  TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.

[283]  J. Rodríguez-Sánchez,et al.  TNF alpha production to TLR2 ligands in active IBD patients. , 2006, Clinical immunology.

[284]  M. Karin.  Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[285]  S. Targan,et al.  Bacterial flagellin is a dominant antigen in Crohn disease. , 2004, The Journal of clinical investigation.

[286]  Shizuo Akira,et al.  MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis , 2004, Journal of Gastroenterology.

[287]  S. Pettersson,et al.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.

[288]  R. Thurman,et al.  Antibiotics prevent liver injury in rats following long-term exposure to ethanol. , 1995, Gastroenterology.

[289]  Michael Karin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 Tables S1 to S4 Gender Disparity in Liver Cancer Due to Sex Differences in Myd88-dependent Il-6 Production , 2022 .